BIOLIFE4D is committed to perfecting the technology to make viable organ replacement a safe, accessible and affordable reality. With BIOLIFE4D, a patient-specific, fully functioning heart will be created through 3D bioprinting and the patientâs own cells, eliminating the challenges of organ rejection and long donor waiting lists that plague existing organ transplant methods.
No articles found.
Genetic Technologies is a leader in the development of genetic technology. Our tes...
Genetic Technologies is a leader in the develop...
Curis is a biotechnology company focused on the development and commercialization ...
Curis is a biotechnology company focused on the...
Anixa is focused on harnessing the bodyâs immune system in the fight against can...
Anixa is focused on harnessing the bodyâs imm...
MiMedxŽ is a biopharmaceutical company developing, manufacturing and marketing reg...
MiMedxŽ is a biopharmaceutical company developi...
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by si...
Arrowhead Pharmaceuticals develops medicines th...
BioSculpture Technology, Inc. (âBSTâ) is a commercial-stage medical device man...
BioSculpture Technology, Inc. (âBSTâ) is a ...
Sigma Labs, Inc. (NASDAQ: SGLB) is a leading provider of quality assurance softwar...
Sigma Labs, Inc. (NASDAQ: SGLB) is a leading pr...
Join the National Investor Network and get the latest information with your interests in mind.